FRA:IUI1 • US46120E6023
The current stock price of IUI1.DE is 416.7 EUR. In the past month the price decreased by -9.34%. In the past year, price decreased by -28.94%.
ChartMill assigns a fundamental rating of 7 / 10 to IUI1.DE. Both the health and profitability get an excellent rating, making IUI1.DE a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months IUI1.DE reported a non-GAAP Earnings per Share(EPS) of 7.53. The EPS increased by 21.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.38% | ||
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| Debt/Equity | 0 |
42 analysts have analysed IUI1.DE and the average price target is 533.68 EUR. This implies a price increase of 28.07% is expected in the next year compared to the current price of 416.7.
For the next year, analysts expect an EPS growth of 14.46% and a revenue growth 15.92% for IUI1.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 15.75 | 109.407B | ||
| 1MDT | MEDTRONIC PLC | 16.18 | 108.304B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.27 | 46.169B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 17.38 | 25.46B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 17.22 | 24.921B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.19 | 24.882B | ||
| BIM | BIOMERIEUX | 18.48 | 10.913B | ||
| DIA | DIASORIN SPA | 16.37 | 4.014B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 17.93 | 3.702B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.44 | 2.311B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA US
Employees: 15638
Phone: 13026587581
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
The current stock price of IUI1.DE is 416.7 EUR. The price increased by 0.11% in the last trading session.
IUI1.DE does not pay a dividend.
IUI1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
IUI1.DE stock is listed on the Frankfurt Stock Exchange exchange.
The Revenue of INTUITIVE SURGICAL INC (IUI1.DE) is expected to grow by 15.92% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.